Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial
Authors:
- 1 October 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 173 (4) , 940-948
Abstract
Norway spruce (Picea abies) produces resin to protect against decomposition by microbial pathogens. In vitro tests have shown that spruce resin has antifungal properties against dermatophytes known to cause nearly 90% of onychomycosis in humans. To confirm previous in vivo observations that a topical resin lacquer provides mycological and clinical efficacy, and to compare this lacquer with topical amorolfine hydrochloride lacquer and systemic terbinafine for treating dermatophyte toenail onychomycosis. In this prospective, randomized, controlled, investigator-blinded study, 73 patients with onychomycosis were randomized to receive topical 30% resin lacquer once daily for 9 months, topical 5% amorolfine lacquer once weekly for 9 months, or 250 mg oral terbinafine once daily for 3 months. The primary outcome measure was complete mycological cure at 10 months. Secondary outcomes were clinical efficacy, cost-effectiveness and patient compliance. At 10 months, complete mycological cure rates with the resin, amorolfine and terbinafine treatments were 13% [95% confidence interval (CI) 0-28], 8% (95% CI 0-19) and 56% (95% CI 35-77), respectively (P ≤ 0·002). At 10 months, clinical responses were complete in four patients (16%) treated with terbinafine, and partial in seven (30%), seven (28%) and nine (36%) patients treated with resin, amorolfine and terbinafine, respectively (P < 0·05). Resin, amorolfine and terbinafine treatments cost €41·6, €56·3 and €52·1, respectively, per patient (P < 0·001). Topical 30% resin lacquer and topical 5% amorolfine lacquer provided similar efficacy for treating dermatophyte toenail onychomycosis. However, orally administered terbinafine was significantly more effective in terms of mycological cure and clinical outcome than either topical therapy at the 10-month follow-up.Keywords
Funding Information
- Repolar Ltd
This publication has 54 references indexed in Scilit:
- Natural coniferous resin lacquer in treatment of toenail onychomycosis: an observational studyMycoses, 2012
- Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild‐to‐moderate toenail onychomycosis: results from three randomized studies using double‐blind vehicle‐controlled and open‐label active‐controlled designsJournal of the European Academy of Dermatology and Venereology, 2011
- In vitro fungistatic effects of natural coniferous resin from Norway spruce (Picea abies)European Journal of Clinical Microbiology & Infectious Diseases, 2011
- Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agentsJournal of the American Academy of Dermatology, 2010
- A meta-analysis comparing efficacy of continuous terbinafine with intermittent itraconazole for toenail onychomycosisIndian Journal of Dermatology, 2010
- Onychomycosis: Diagnosis and definition of cureJournal of the American Academy of Dermatology, 2007
- Modulation of linear nail growth to treat diseases of the nailJournal of the American Academy of Dermatology, 2004
- Common Fungal Infections of the Feet in Patients with Diabetes MellitusDrugs & Aging, 2004
- Superficial fungal infections in 102 renal transplant recipients: a case-control studyJournal of the American Academy of Dermatology, 2003
- Onychomycosis: A significant medical disorderJournal of the American Academy of Dermatology, 1996